Johnson & Johnson Innovation’s Science & Partnering Forum

J&J Innovation Asia Pacific will partner with the Janssen R&D Immunology TA to host a hybrid onsite and online Science and Partnering forum convening global and regional leaders to engage in a dialogue on opportunities for accelerating solutions for patients with immune-mediated diseases through deals and incubation. The event will focus on engaging audiences of early-stage innovators in China, Japan and South Korea. The event will bring together internal and external experts to present and engage in panel discussions on current and future trends in immunology R&D and commercialization, as well as Janssen and Johnson & Johnson’s innovations approach to partnership with early-stage innovators in this therapeutic area, with a particular focus on the topics related to small molecule and platform solutions that address immune-mediated diseases impacting patients everywhere.